Botwood Nicholas A.J.
Head of R&D, CMO
Botwood Nicholas A.J. has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 12, 2026.
On the most recent filing, Botwood Nicholas A.J. is listed as Head of R&D, CMO at Syndax Pharmaceuticals Inc. Inside the rolling window, Botwood Nicholas A.J. reported no open-market purchases and 2 open-market sales totaling $1.2M in SNDX. The largest disclosed transaction in the window is a sale of 34,280 SNDX shares on Jun 11, 2026, worth $617K.
Companies traded
Other insiders at SNDX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Botwood Nicholas A.J. made?
Botwood Nicholas A.J. has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Botwood Nicholas A.J. trade?
Botwood Nicholas A.J. has filed SEC Form 4 disclosures for 1 company, including SNDX.
When was Botwood Nicholas A.J.'s most recent SEC Form 4 filing?
Botwood Nicholas A.J.'s most recent SEC Form 4 filing on Tracefour is dated Jun 12, 2026.
What is Botwood Nicholas A.J.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Botwood Nicholas A.J. is listed as Head of R&D, CMO.
What is Botwood Nicholas A.J.'s total buy and sell value in the current window?
Inside the rolling retention window, Botwood Nicholas A.J. bought $0 and sold $1.2M based on SEC Form 4 filings.
What was Botwood Nicholas A.J.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 34,280 SNDX shares on 2026-06-11, worth $617K, per SEC Form 4 filings.